CLINICAL_TRIALS
trial_result
· 2015-05-01
Clinical Trial Update: Study to Reduce Symptoms of Premature Beats With Ranolazine [Phase 4]
Summary
This document reports a Phase 4 clinical trial evaluating ranolazine to reduce symptoms of premature ventricular contractions.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Walter Reed National Military Medical Center | Conditions: Premature Ventricular Beats | Phase 4 | Status: UNKNOWN